Article Text

Download PDFPDF
A critical pathway reduced resource use without compromising safety and effectiveness in community acquired pneumonia

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Sources of funding: Janssen-Ortho Inc and Medical Research Council of Canada–Pharmaceutical Manufacturers' Association of Canada Awards Program.

  • For correspondence: Dr B G Feagan, London Clinical Trials Research Group, John P Robarts Research Institute, 100 Perth Drive, London, Ontario N6A 5K8, Canada. Fax +1 519 663 3807.

  • * See glossary.